South Rampart Pharma Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$3.2M
- Investors
-
6
South Rampart Pharma General Information
Description
Developer of a clinical-stage biotech company designed to address the need for a safe and effective approach to relieving pain. The company develops synthesized and characterized new non-opioid and non-liver toxic molecules that activate pain signaling pathways in the midbrain's periaqueductal grey (PAG) region, enabling patients to overcome risks associated with current pain medicines, including lack of abuse as a non-opioid and no liver toxicity.
Contact Information
Website
www.southrampartpharma.comCorporate Office
- 7 highland Avenue
- San Rafael, CA 94901
- United States
Corporate Office
- 7 highland Avenue
- San Rafael, CA 94901
- United States
South Rampart Pharma Timeline
South Rampart Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series A) | 22-Jan-2025 | $3.2M | Completed | Clinical Trials - Phase 2 | ||
| 6. Grant | Completed | Clinical Trials - Phase 1 | ||||
| 5. Grant | 15-Sep-2023 | Completed | Clinical Trials - Phase 1 | |||
| 4. Grant | 01-May-2023 | Completed | Clinical Trials - Phase 1 | |||
| 3. Corporate | 01-Oct-2022 | Completed | Clinical Trials - Phase 2 | |||
| 2. Grant | 01-Sep-2021 | $1.9M | $4M | Completed | Clinical Trials - Phase 1 | |
| 1. Corporate | 01-Sep-2020 | $4M | $4M | Completed | Clinical Trials - Phase 1 |
South Rampart Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
South Rampart Pharma Comparisons
Industry
Financing
Details
South Rampart Pharma Competitors (1)
One of South Rampart Pharma’s competitors is Centrexion Therapeutics, a Venture Capital-Backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Centrexion Therapeutics | Venture Capital-Backed | Boston, MA |
South Rampart Pharma Patents
South Rampart Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250339391-A1 | Methods for effective management of pain | Pending | 18-Apr-2024 | ||
| AU-2024234362-A1 | Nanoparticle formulations for a non-opioid drug | Pending | 10-Mar-2023 | ||
| EP-4676444-A1 | Nanoparticle formulations for a non-opioid drug | Pending | 10-Mar-2023 | ||
| WO-2024191741-A1 | Nanoparticle formulations for a non-opioid drug | Inactive | 10-Mar-2023 | ||
| US-11458142-B2 | Compositions and methods for ameliorating pain | Active | 25-Aug-2017 | A61K31/5375 |
South Rampart Pharma Signals
South Rampart Pharma Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Gulf South Angels | Angel Group | Minority | ||
| Ochsner Ventures | Corporate Venture Capital | Minority | ||
| Small Business Innovation Research and Small Business Technology Transfer Programs | Government | Minority | ||
| Ochsner Health | Corporation | Minority | ||
| National Institutes of Neurological Disorders and Stroke | Government |
South Rampart Pharma FAQs
-
When was South Rampart Pharma founded?
South Rampart Pharma was founded in 2016.
-
Where is South Rampart Pharma headquartered?
South Rampart Pharma is headquartered in San Rafael, CA.
-
What is the size of South Rampart Pharma?
South Rampart Pharma has 4 total employees.
-
What industry is South Rampart Pharma in?
South Rampart Pharma’s primary industry is Drug Discovery.
-
Is South Rampart Pharma a private or public company?
South Rampart Pharma is a Private company.
-
What is the current valuation of South Rampart Pharma?
The current valuation of South Rampart Pharma is .
-
What is South Rampart Pharma’s current revenue?
The current revenue for South Rampart Pharma is .
-
How much funding has South Rampart Pharma raised over time?
South Rampart Pharma has raised $9.1M.
-
Who are South Rampart Pharma’s investors?
Gulf South Angels, Ochsner Ventures, Small Business Innovation Research and Small Business Technology Transfer Programs, Ochsner Health, and National Institutes of Neurological Disorders and Stroke are 5 of 6 investors who have invested in South Rampart Pharma.
-
Who are South Rampart Pharma’s competitors?
Centrexion Therapeutics is a competitor of South Rampart Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process